Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 May 1;201(9):1120–1134. doi: 10.1164/rccm.201910-1975OC

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2020 by the American Thoracic Society

This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/). For commercial usage and reprints, please contact Diane Gern (dgern@thoracic.org).

PMC Copyright notice

Figure 11. — (A–C) Effects of short (1–3 d) or long (1–14 d) rhIGF-1 (recombinant human insulin-like growth factor-1)/BP3 (binding peptide 3) treatment on distal right ventricular function (A) and lung function (B and C) in infant rats at 14 days exposure to hyperoxia (HO). Box plots represent median, interquartile range, and minimum–maximum data points. Animal numbers per study group: control rats = 15; HO = 10; rhIGF-BP3 Days 1 to 3, 2 mg/kg = 10; and rhIGF-BP3 Days 1 to 14, 2 mg/kg = 15. LV+S = left ventricle plus septum; RV = right ventricle.